Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Pharming Group N.V.
Pharming announces public cash offer to the shareholders of Abliva AB
December 15, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces positive topline data in pediatric clinical trial of leniolisib
December 11, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in November investor conference
November 05, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports third quarter 2024 financial results and provides business update
October 24, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report third quarter 2024 financial results on October 24
October 10, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
October 10, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
September 26, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in September investor conferences
September 04, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports second quarter and first half 2024 financial results and provides business update
August 01, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report second quarter and first half 2024 financial results on August 1
July 18, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in June investor conferences
June 03, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
May 21, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in May investor conference
May 20, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports first quarter 2024 financial results and provides business update
May 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
April 24, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
April 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in April investor conferences
April 03, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports fourth quarter and full year 2023 financial results
March 14, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
February 29, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in February investor conferences
February 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
January 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
December 13, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
November 21, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in November investor conferences
November 01, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports third quarter 2023 financial results
October 26, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report third quarter 2023 financial results on October 26
October 12, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
September 25, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.